Skip to main content

Table 2 Independent samples t test to compare the differences between the means in two country groups with the cut point of 2.36 (TFR). Sample size 95 indicates countries with high TFR, 83 low TFR

From: Greater family size is associated with less cancer risk: an ecological analysis of 178 countries

 

All countries, n = 178

Developed Countries, n = 98

Developing Countries, n = 80

Sample size

Mean

Mean difference

t

Sample size

Mean

Mean difference

t

Sample size

Mean

Mean difference

t

All cancers excl. Non-melanoma skin cancer (C00–97, but C44) - all ages: both sexes

95

123.81

−96.58

−12.50***

26

141.57

−88.17

−6.67***

69

117.11

−42.01

−3.89***

83

220.39

  

72

   

11

   

All cancers excl. Non-melanoma skin cancer (C00–97, but C44)- all ages: female

95

129.73

−72.58

−10.67***

26

143.80

−66.91

−5.88***

69

124.42

−22.87

−2.23*

83

202.31

  

72

   

11

   

All cancers excl. Non-melanoma skin cancer (C00–97, but C44) - all ages: male

95

120.09

− 128.54

−13.45***

26

144.41

− 114.97

−7.00***

69

110.93

−67.41

−5.03***

83

248.64

  

72

   

11

   

All cancers excl. Non-melanoma skin cancer (C00–97, but C44) – 0-49: both sexes

95

35.98

−36.82

−13.37***

26

43.04

−32.18

−6.49***

69

33.32

−23.58

−6.73***

83

72.80

  

72

   

11

   

All cancers excl. Non-melanoma skin cancer (C00–97, but C44) – 0-49: female

95

47.01

−45.90

−12.87***

26

58.15

−38.23

−6.06***

69

42.82

−27.40

−6.06***

83

92.91

  

72

   

11

   

All cancers excl. Non-melanoma skin cancer (C00–97, but C44) – 0-49: male

95

25.24

−28.28

−12.68***

26

28.57

−26.50

−6.52***

69

23.99

−19.38

−6.41***

83

53.52

  

72

   

11

   

Bladder (C67), all ages

95

2.91

−4.76

−9.48***

26

4.03

−4.12

− 4.75***

69

2.49

−2.03

−2.70**

83

7.67

  

72

   

11

   

Breast (C50), all ages

95

31.01

−29.29

−10.43***

26

38.65

−25.47

−5.46***

69

28.13

−7.15

−1.80

83

60.30

  

72

   

11

   

Cervix uteri (C53), all ages

95

26.18

13.24

7.17***

26

20.85

8.29

4.02***

69

28.19

12.77

2.61*

83

12.94

  

72

   

11

   

Colorectum (C18–21), all ages

95

7.63

−16.04

−13.12***

26

11.34

−13.91

−6.68***

69

6.24

−7.11

−4.51***

83

23.67

  

72

   

11

   

Corpus uteri (C54), all ages

95

5.15

−6.91

−8.91***

26

7.23

−5.21

−4.06***

69

4.37

−5.24

−3.76***

83

12.06

  

72

   

11

   

Lung (C33–34), all ages

95

7.43

−17.12

−12.62***

26

11.42

−13.76

−6.16***

69

5.93

−14.55

−5.94***

83

24.55

  

72

   

11

   

Melanoma of skin (C43), all ages

95

1.16

−4.80

−6.35***

26

1.67

−5.05

−3.38***

69

0.97

−0.07

−0.25

83

5.96

  

72

   

11

   

Ovary (C56), all ages

95

4.67

−3.39

−9.27***

26

5.09

−3.31

−5.56***

69

4.51

−1.28

−1.95

83

8.06

  

72

   

11

   

Stomach (C16), all ages

95

6.29

−3.32

−3.71***

26

7.24

−2.10

−1.50

69

5.92

−5.38

−2.90**

83

9.61

  

72

   

11

   
  1. Note: Significance level: ***p < 0.001, **p < 0.01, *p < 0.05
  2. Data sources and variable meanings:
  3. The International Agency for Research published cancer incidence rates (per 100,000 in 2012) of all cancers incidence rate by sex (total, male and female, 0–49 years and all ages respectively); bladder, breast, cervix uteri, colorectum, corpus uteri, ovary and stomach
  4. The World Bank data: Total Fertility Rate (TFR, the mean number of children born to a woman between 2009 and 2011). The TFR 2.36 was used as the cut point to stratify the total countries (n = 178)
  5. For each cancer variable, the mean of countries with TRR ≥2.36 was reported in the first line, and the mean of countries with TFR < 2.36 was reported in the second line. Sample sizes: n = 95 and 83